Electromed (ELMD)
(Delayed Data from AMEX)
$20.29 USD
-0.21 (-1.02%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $20.15 -0.14 (-0.69%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Electromed, Inc. [ELMD]
Reports for Purchase
Showing records 1 - 20 ( 46 total )
Company: Electromed, Inc.
Industry: Medical - Instruments
Optimized Entry and Exit Levels for ELMD 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Discontinuation of Research Coverage
Provider: Feltl & Company
Company: Electromed, Inc.
Industry: Medical - Instruments
Q2 FY2017 ahead of our estimates, sales force expanding - reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q1 FY2017 light of our estimates, sales force expanding - reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q4 FY2016 light of our estimates, sales force expanding - reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q4 FY2016 light of our estimates, sales force expanding - reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q3 FY2016 sales ahead of estimates - raising target to $6.00, reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q2 FY2016 well ahead of estimate - raising target to $4.50, reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Q3 FY2015 results ahead on revenue, net income inline, reiterate BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Solid Execution in Q4 FY2014 electrifies sales and EPS, beating estimates.
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q3 FY2014 sales ahead, EPS missed on lower gross margin, higher tax expense
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Q1 FY2014 results below expectations, flirting with company?s low watermark
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q4 FY2013 results above expectations, turnaround appears to be taking hold
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q3 FY2013 results below expectations, but all-time record referrals generated
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Electromed, Inc.
Industry: Medical - Instruments
Q2 FY2013 results below expectations, FY2013 setting up as a transition year
Provider: FELTL & COMPANY
Analyst: HAYNOR B